St. Jude Medical wins CE Mark approval in the European Union for its Eon Mini, the smallest in its line of rechargeable neurostimulators for treating chronic migraine.

St. Jude Medical (NYSE:STJ) won European regulatory approval for its Eon Mini neurostimulator, which the company calls the smallest rechargeable device for treatment of chronic migraine.

The Eon Mini is a pacemaker-like device that delivers mild electrical pulses to the occipital nerves, located at the back of the head, to help migraine patients who aren't well managed by drugs.